Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy D Hanson

Showing results (41-50 of 78) with videos related to

Pageof 8
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 1, 2004
Population-based laboratory surveillance for Escherichia coli-producing extended-spectrum beta-lactamases: importance of community isolates with blaCTX-M genesJohann D D Pitout, Nancy D Hanson, Deirdre L Church, et al.
Microbiologyopen|April 13, 2019
lptG contributes to changes in membrane permeability and the emergence of multidrug hypersusceptibility in a cystic fibrosis isolate of Pseudomonas aeruginosaLucas B Harrison, Randal C Fowler, Baha Abdalhamid, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|December 10, 2013
Purification, crystallization and preliminary X-ray analysis of IMP-18, a class B carbapenemase from Pseudomonas aeruginosaTakamitsu Furuyama, Yoshikazu Ishii, Norimasa Ohya, et al.
Diagnostic Microbiology and Infectious Disease|September 24, 2004
Multidrug resistance associated with mexXY expression in clinical isolates of Pseudomonas aeruginosa from a Texas hospitalDaniel J Wolter, Ellen Smith-Moland, Richard V Goering, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 9, 2008
Emergence of carbapenem resistance in Pseudomonas aeruginosa isolates from a patient with cystic fibrosis in the absence of carbapenem therapyDaniel J Wolter, Dee Acquazzino, Richard V Goering, et al.
The Journal of Antimicrobial Chemotherapy|October 26, 2006
In vitro development of resistance to DX-619 and other quinolones in enterococciPaul A Wickman, Jennifer A Black, Ellen Smith Moland, et al.
Antimicrobial Agents and Chemotherapy|December 6, 2006
Klebsiella pneumoniae isolate producing at least eight different beta-lactamases, including AmpC and KPC beta-lactamasesEllen Smith Moland, Seong Geun Hong, Kenneth S Thomson, et al.
Infection Control and Hospital Epidemiology|March 11, 2021
Intrapatient transfer of an uncommon carbapenemase in NebraskaAlyssa K W Maclean, Stacey Morrow, Anum Abbas, et al.
Journal of Clinical Microbiology|July 18, 2025
First description of the performance of the VITEK MITUBE device used with MALDI-TOF mass spectrometry to achieve identification of gram-negative bacteria directly from positive blood culture brothDaniel D Rhoads, Nancy D Hanson, Kaley Reedy, et al.
Journal of Clinical Microbiology|September 7, 2006
Prevalence of newer beta-lactamases in gram-negative clinical isolates collected in the United States from 2001 to 2002Ellen S Moland, Nancy D Hanson, Jennifer A Black, et al.
Pageof 8

Showing results (41-50 of 78) with videos related to

Sort By:
Pageof 8
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 1, 2004
Population-based laboratory surveillance for Escherichia coli-producing extended-spectrum beta-lactamases: importance of community isolates with blaCTX-M genesJohann D D Pitout, Nancy D Hanson, Deirdre L Church, et al.
Microbiologyopen|April 13, 2019
lptG contributes to changes in membrane permeability and the emergence of multidrug hypersusceptibility in a cystic fibrosis isolate of Pseudomonas aeruginosaLucas B Harrison, Randal C Fowler, Baha Abdalhamid, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|December 10, 2013
Purification, crystallization and preliminary X-ray analysis of IMP-18, a class B carbapenemase from Pseudomonas aeruginosaTakamitsu Furuyama, Yoshikazu Ishii, Norimasa Ohya, et al.
Diagnostic Microbiology and Infectious Disease|September 24, 2004
Multidrug resistance associated with mexXY expression in clinical isolates of Pseudomonas aeruginosa from a Texas hospitalDaniel J Wolter, Ellen Smith-Moland, Richard V Goering, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 9, 2008
Emergence of carbapenem resistance in Pseudomonas aeruginosa isolates from a patient with cystic fibrosis in the absence of carbapenem therapyDaniel J Wolter, Dee Acquazzino, Richard V Goering, et al.
The Journal of Antimicrobial Chemotherapy|October 26, 2006
In vitro development of resistance to DX-619 and other quinolones in enterococciPaul A Wickman, Jennifer A Black, Ellen Smith Moland, et al.
Antimicrobial Agents and Chemotherapy|December 6, 2006
Klebsiella pneumoniae isolate producing at least eight different beta-lactamases, including AmpC and KPC beta-lactamasesEllen Smith Moland, Seong Geun Hong, Kenneth S Thomson, et al.
Infection Control and Hospital Epidemiology|March 11, 2021
Intrapatient transfer of an uncommon carbapenemase in NebraskaAlyssa K W Maclean, Stacey Morrow, Anum Abbas, et al.
Journal of Clinical Microbiology|July 18, 2025
First description of the performance of the VITEK MITUBE device used with MALDI-TOF mass spectrometry to achieve identification of gram-negative bacteria directly from positive blood culture brothDaniel D Rhoads, Nancy D Hanson, Kaley Reedy, et al.
Journal of Clinical Microbiology|September 7, 2006
Prevalence of newer beta-lactamases in gram-negative clinical isolates collected in the United States from 2001 to 2002Ellen S Moland, Nancy D Hanson, Jennifer A Black, et al.
Pageof 8